Search for: "Apotex" Results 481 - 500 of 1,051
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Dec 2016, 7:23 am by Robert Kraft
” Novartis AG unit Sandoz, Apotex, and Mylan “have said in court filings that they are prepared to launch generic versions of Crestor, which lost patent protection earlier this year. [read post]
13 Mar 2009, 12:30 am
Apotex (not participating in the decision to grant cert, vacate, and remand for reconsideration in light of Levine), a case involving Pfizer as a party. [read post]
30 Jul 2012, 9:55 pm by Patent Docs
Patent Nos. 6,716,830 ("Ophthalmic Antibiotic Compositions Containing Moxifloxacin," issued April 6, 2004) and 7,671,070 ("Method of Treating Ophthalmic Infections with Moxifloxacin Compositions," issued March 2, 2010) following a Paragraph IV certification as part of Apotex's filing of an ANDA to manufacture... [read post]
1 Jul 2012, 8:49 pm by Patent Docs
Apotex for Pharma Patents (Strafford) - 1:00 - 2:30 pm (EDT) July 17-19, 2012 - Product and Pipeline Enhancement for Generics*** (marcus evans) - Washington, DC July 30-31, 2012 - Freedom to Operate*** (American Conference Institute) - Philadelphia, PA July 30 to August 1, 2012 - Intensive Patent Law Seminar (Chisum Patent Academy) - Seattle, WA... [read post]
20 Mar 2007, 8:19 am
See also Star-Ledger addresses Apotex launch of generic PLAVIX . [read post]
2 Nov 2009, 1:20 pm
’s judgment for the Court in Apotex Inc. v. [read post]
8 Jul 2012, 8:58 pm by Patent Docs
Apotex for Pharma Patents (Strafford) - 1:00 - 2:30 pm (EDT) July 17-19, 2012 - Product and Pipeline Enhancement for Generics*** (marcus evans) - Washington, DC July 18, 2012 - EPO Biotechnology Case Law Update (D Young & Co.) - 4:00 am, 7:00 am, 12:00 pm (all times EDT) July 30-31, 2012 - Freedom to Operate***... [read post]
29 Jun 2007, 7:56 pm
  They join Mylan, which launched in March, and Apotex, which launched in May. [read post]
26 May 2010, 3:01 pm by Oliver G. Randl
In its written submission, […] Apotex declares that it has carried out four trials for the purpose of presenting them in the law suite in the UK and explains how the experimental conditions under which the trials were carried out could be guaranteed. [read post]
21 Dec 2016, 7:18 am by Gene Quinn
The Apotex IPRs were settled on December 16, 2015, prior to any institution determination. [read post]
18 Aug 2008, 3:08 pm
Apotex Corp., No. 07-61665-CIV, 2008 WL 2047979 (S.D. [read post]
3 Oct 2007, 10:00 pm
Also telling to the Judge was that Apotex had lost equivalent litigation in the US and elsewhere. [read post]
29 Mar 2011, 9:19 pm by Marie Louise
(The IP Factor) Products Actonel (Risedronate) – US: Warner Chilcott files patent infringement complaint against Mylan in response to Para IV certification (Patent Docs) Actos (Pioglitazone) – US: Takeda files patent infringement suit against Apotex following Para IV challenge (Patent Docs) Antara (Fenofibrate) – US: Lupin files patent infringement lawsuits against Mylan, Apotex following Para IV certification (Patent Docs) Drospirenone, Ethinylestradiol –… [read post]
5 Aug 2009, 5:35 am
(Spicy IP) Coversyl (Perindopril) – Canada: Court of Appeal upholds Trial Division finding of patent validity and infringement: Apotex v ADIR (Pharmacapsules@Gowlings) Cozaar (Losartan) – France: French Patent Office grants paediatric extension of French SPC for Losartan (The SPC Blog) Cozaar/Hyzaar (Losartan) – US: FDA prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva Pharmaceuticals v Sebelius (FDA Law Blog) Diflucan… [read post]